Skip to Main Content U.S. Department of Energy
Economic Development Office

Tri-Cities Tech Business Update

December 2008 Issue

*Medical isotope product receives favorable clinical review, hires new vice-president

IsoRay Medical, based in Richland, Wash., was featured in the November 2008 edition of the peer-reviewed journal Brachytherapy. The article recommended the company's ProxcelanTM Cesium-131 brachytherapy seeds for treating prostate cancer. Brachytherapy treatment includes implanting titanium capsules containing the radioisotope directly into the cancerous prostate gland. The journal article is the first full clinical review of the treatment. IsoRay also hired Anthony Pasqualone as Vice President of Business Development in charge of Sales. Pasqualone has been involved in marketing brachytherapy extensively since 1989 including serving as the national sales manager at Theragenics Corporation, working with the team at Oncura, and most recently serving as vice-president of sales at SourceTech Medical. Contact at (509) 375-1202.

PNNL's EDO

News & Events

Programs & Resources

Share This

Share This!

Additional Information

Subscribe

Current Issue

Back Issues